Melatonin inhibits cell growth and migration, but promotes apoptosis in gastric cancer cell line, SGC7901. (Q34616091)

3 August 2017

title

Melatonin inhibits cell growth and migration, but promotes apoptosis in gastric cancer cell line, SGC7901. (English)

1 reference

3 August 2017

0 references

1 reference

1 reference

1 reference

S Zhang

1 reference

3 August 2017

Y Qi

1 reference

3 August 2017

H Zhang

1 reference

3 August 2017

W He

1 reference

3 August 2017

Q Zhou

1 reference

3 August 2017

S Gui

1 reference

3 August 2017

Y Wang

1 reference

3 August 2017

publication date

11 March 2013

1 reference

Biotechnic & Histochemistry

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

281-289

1 reference

Melatonin: a hormone that modulates pain

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Melatonin: circadian rhythm regulator, chronobiotic, antioxidant and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Gastrointestinal melatonin: localization, function, and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Prospects of the clinical utilization of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Melatonin and the immune system in aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Combination of melatonin and a peroxisome proliferator-activated receptor-gamma agonist induces apoptosis in a breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Melatonin and melatonergic drugs on sleep: possible mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Effect of melatonin on apoptosis, proliferation and differentiation of urothelial cells after cyclophosphamide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

Melatonin may be synthesised in enterochromaffin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10520295.2013.769633

10.3109/10520295.2013.769633

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference